Uranium ETF shines while ARK Genomic Revolution ETF struggles
In a striking contrast of fortunes in the Exchange-Traded Fund (ETF) market on Friday, the Uranium ETF outperformed its peers, while the ARK Genomic Revolution ETF struggled.
The Uranium ETF reported a significant rise of approximately 3.9%, primarily driven by the robust performance of certain components of the fund. Specifically, UR Energy and Uranium Energy (NYSE:UEC) both appreciated by about 6.5%. This surge marked a noteworthy development in the ETF market.
On the other hand, the ARK Genomic Revolution ETF didn't fare as well on the same day, recording a decline of around 7.4%. Certain components of this ETF contributed to its weaker performance. Shares of Exact Sciences (NASDAQ:EXAS) and Intellia Therapeutics (NASDAQ:NTLA) fell by approximately 1.9% and 1.8% respectively.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Related Articles
Uranium ETF shines while ARK Genomic Revolution ETF struggles
Goodyear Tire to cut 700 jobs, sell retail stores in Asia Pacific
UAW strikes more GM, Stellantis facilities, cites progress in talks with Ford
